Original Source(s)
Related Content
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min
FDA Approves New Iohexol Vials
The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.
July 17, 2026
-
2 min
Infections Lead Thoracic CT Findings in SLE
Researchers characterize spectrum of pulmonary and extrathoracic involvement in systemic lupus erythematosus.
May 7, 2026
-
3 min